Full Press Release Details
NEW HOPE, Pa., Feb. 20, 2025 (GLOBE NEWSWIRE) -- Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), a biomedical company accelerating high-impact technologies to patients through risk-reward sharing partnerships, today announced that company management will present and be available for one-on-one meetings at multiple upcoming investor conferences.
Details on the Company’s presence at these conferences are shown below.
TD Cowen 45th Annual Healthcare Conference
Format: Corporate Presentation
Barclays 27th Annual Global Healthcare Conference
Format: Fireside Chat
Date: March 13, 2025
Live audio webcasts of the TD Cowen presentation can be accessed through the Investors section of the Company’s website at https://investors.orchestrabiomed.com/news-events/events. An archived replay of the webcast will be available on the Company’s website for 90 days following the live event.
The Company will also be hosting 1x1 meetings with investors at the B. Riley Securities Precision Oncology & RadioPharma Conference on February 28, 2025.
About Orchestra BioMed
References to Websites and Social Media Platforms
References to information included on, or accessible through, websites and social media platforms do not constitute incorporation by reference of the information contained at or available through such websites or social media platforms, and you should not consider such information to be part of this press release.